Literature DB >> 477186

Binding of human serum ferritin to concanavalin A.

M Worwood, S J Cragg, M Wagstaff, A Jacobs.   

Abstract

1. A high proportion of the ferritin in normal serum binds to concanavalin A. Binding is prevented by the addition of alpha-D-methylglucoside to the reaction mixture. 2. Ferritin in extracts of normal heart, liver and spleen or serum ferritin from patients with massive hepatic necrosis does not bind to concanavalin A. 3. Isoelectric focusing of preparations of serum ferritin from patients with primary haemochromatosis shows that the ferritin fraction binding to concanavalin A consists, predominantly, of the more acidic isoferritins. 4. These findings suggest that carbohydrate residues may be added to ferritin during its secretion into the plasma. Glycosylation may account for the heterogeneity of serum ferritin on isoelectric focusing. 5. Direct release of intracellular ferritin from damaged tissue may be indicated by an increase in the proportion of circulating ferritin which does not bind to concanavalin A. Such an increase has been found in sera from patients with iron overload.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477186     DOI: 10.1042/cs0560083

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

1.  Decoupling ferritin synthesis from free cytosolic iron results in ferritin secretion.

Authors:  Ivana De Domenico; Michael B Vaughn; Prasad N Paradkar; Eric Lo; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

2.  Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis.

Authors:  Zhao Wang; Yini Wang; Jingshi Wang; Cuicui Feng; Liping Tian; Lin Wu
Journal:  Int J Hematol       Date:  2009-08-05       Impact factor: 2.490

Review 3.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

4.  Serum ferritin and binding of serum ferritin to concanavalin A as a tumor marker in patients with primary liver cell cancer and chronic liver disease.

Authors:  R W Chapman; M F Bassendine; M Laulicht; A Gorman; H C Thomas; S Sherlock; A V Hoffbrand
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

5.  Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Authors:  H E Broxmeyer; J Bognacki; M H Dorner; M de Sousa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

6.  Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease.

Authors:  R W Chapman; A Gorman; M Laulicht; M A Hussain; S Sherlock; A V Hoffbrand
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

7.  Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease.

Authors:  S Vignes; G Le Moël; B Fautrel; B Wechsler; P Godeau; J C Piette
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

8.  A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload.

Authors:  Caroline Kannengiesser; Anne-Marie Jouanolle; Gilles Hetet; Annick Mosser; Françoise Muzeau; Dominique Henry; Edouard Bardou-Jacquet; Martine Mornet; Pierre Brissot; Yves Deugnier; Bernard Grandchamp; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

Review 9.  Serum ferritin and malignant tumours.

Authors:  A Jacobs
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

10.  Basic isoferritin and hypercalcaemia in renal cell carcinoma.

Authors:  G J Mufti; T J Hamblin; J Stevens
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.